MDT

94.52

-1.83%↓

VEEV

286.52

-0.29%↓

A

138.17

-0.78%↓

HQY

93.3

-1.79%↓

PHR.US

22.89

+0.79%↑

MDT

94.52

-1.83%↓

VEEV

286.52

-0.29%↓

A

138.17

-0.78%↓

HQY

93.3

-1.79%↓

PHR.US

22.89

+0.79%↑

MDT

94.52

-1.83%↓

VEEV

286.52

-0.29%↓

A

138.17

-0.78%↓

HQY

93.3

-1.79%↓

PHR.US

22.89

+0.79%↑

MDT

94.52

-1.83%↓

VEEV

286.52

-0.29%↓

A

138.17

-0.78%↓

HQY

93.3

-1.79%↓

PHR.US

22.89

+0.79%↑

MDT

94.52

-1.83%↓

VEEV

286.52

-0.29%↓

A

138.17

-0.78%↓

HQY

93.3

-1.79%↓

PHR.US

22.89

+0.79%↑

Search

CareDx Inc

Open

SectorGezondheidszorg

14.49 0.76

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.21

Max

14.76

Belangrijke statistieken

By Trading Economics

Inkomsten

1.8M

-8.6M

Verkoop

2M

87M

K/W

Sectorgemiddelde

13.838

36.442

Winstmarge

-9.885

Werknemers

644

EBITDA

9.3M

-4M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+17% upside

Dividenden

By Dow Jones

Volgende Winsten

3 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

72M

773M

Vorige openingsprijs

13.73

Vorige sluitingsprijs

14.49

Nieuwssentiment

By Acuity

50%

50%

166 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

CareDx Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 okt 2025, 22:33 UTC

Winsten

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 okt 2025, 22:21 UTC

Belangrijke Marktbewegers

Dentsply Sirona Shares Rise After SEC Probe Ends

14 okt 2025, 19:27 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 okt 2025, 17:56 UTC

Belangrijke Marktbewegers

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 okt 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 okt 2025, 22:12 UTC

Marktinformatie
Winsten

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 okt 2025, 21:40 UTC

Winsten

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 okt 2025, 21:39 UTC

Winsten

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 okt 2025, 21:38 UTC

Winsten

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 okt 2025, 21:06 UTC

Winsten

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 okt 2025, 20:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

14 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

14 okt 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

14 okt 2025, 20:50 UTC

Marktinformatie
Winsten

Health Care Roundup: Market Talk

14 okt 2025, 20:13 UTC

Winsten

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 okt 2025, 20:01 UTC

Winsten

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 okt 2025, 19:21 UTC

Marktinformatie
Winsten

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 okt 2025, 19:12 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 okt 2025, 19:08 UTC

Marktinformatie

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 okt 2025, 19:02 UTC

Marktinformatie

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 okt 2025, 18:59 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 okt 2025, 18:58 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 okt 2025, 18:58 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 okt 2025, 18:56 UTC

Acquisities, Fusies, Overnames

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 okt 2025, 18:46 UTC

Winsten

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 okt 2025, 18:04 UTC

Winsten

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 okt 2025, 18:01 UTC

Marktinformatie

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 okt 2025, 17:54 UTC

Winsten

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 okt 2025, 17:50 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

14 okt 2025, 17:50 UTC

Marktinformatie

Lower Dollar Provides Some Strength in Grains -- Market Talk

Peer Vergelijking

Prijswijziging

CareDx Inc Prognose

Koersdoel

By TipRanks

17% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 17 USD  17%

Hoogste 22 USD

Laagste 14 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor CareDx Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

2

Buy

5

Hold

0

Sell

Technische score

By Trading Central

14.77 / 18.49Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

166 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat